NASDAQ | TSX: ACB
EDMONTON, AB, Sept. 7, 2021 /PRNewswire/ - Aurora Cannabis
Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the
Canadian company defining the future of cannabinoids worldwide,
announced today that it has scheduled a conference call to discuss
the results for its fourth quarter and full fiscal year 2021 on
Tuesday, September 21, 2021 at
5:00 p.m. Eastern Time | 3:00 p.m. Mountain Time. The Company will report
its financial results for the fourth quarter and full fiscal year
2021 after the close of markets that same day.
Conference Call Details
DATE:
|
|
Tuesday, September
21, 2021
|
TIME:
|
|
5:00 p.m. Eastern
Time | 3:00 p.m. Mountain Time
|
WEBCAST:
|
|
http://public.viavid.com/index.php?id=146159
|
Miguel Martin, Chief Executive
Officer, and Glen Ibbott, Chief
Financial Officer, will host the conference call and question and
answer period. Investors may submit questions in advance or during
the conference call through the weblink listed above. This weblink
has also been posted to the Company's Investor Relations webpage at
https://investor.auroramj.com/ under "News & Events".
Additionally, Aurora has announced that along with the filing of
its annual financial statements, it expects to file other annual
disclosure documents – including the Annual Information Form.
Furthermore, Aurora announced that it has scheduled its Annual
General Meeting of shareholders, which due to the COVID-19
pandemic, will be held virtually on Friday,
November 12, 2021 at 12 p.m. Eastern
Time | 10:00 a.m. Mountain
Time. In conjunction with the meeting, Aurora expects to
file its Information Circular and related proxy materials, which
will be available for download under its profile on both SEDAR and
EDGAR.
About Aurora
Aurora is a global leader in the cannabis industry serving both
the medical and consumer markets. Headquartered in Edmonton, Alberta, Aurora is a pioneer in
global cannabis dedicated to helping people improve their lives.
The Company's brand portfolio includes Aurora, Aurora Drift, San
Rafael '71, Daily Special, AltaVie, MedReleaf, CanniMed, Whistler,
and Reliva CBD. Driven by science and innovation, and with a focus
on high-quality cannabis products, Aurora's brands continue to
break through as industry leaders in the medical, performance,
wellness and recreational markets wherever they are launched. For
more information, please visit our website at www.auroramj.com.
Aurora's common shares trade on the NASDAQ and TSX under the
symbol "ACB" and is a constituent of the S&P/TSX Composite
Index.
Forward Looking Statements
This news release includes statements containing certain
"forward-looking information" within the meaning of applicable
securities law ("forward-looking statements"). Forward-looking
statements are frequently characterized by words such as "plan",
"continue", "expect", "project", "intend", "believe", "anticipate",
"estimate", "may", "will", "potential", "proposed" and other
similar words, or statements that certain events or conditions
"may" or "will" occur. Forward-looking statements made in this news
release include statements regarding: the timing for reporting of
our financial results for the fourth quarter and full fiscal year
2021 and associated conference call, as well as timing for our
Annual General Meeting and filing of related proxy materials. These
forward-looking statements are only predictions. Various
assumptions were used in drawing the conclusions or making the
projections contained in the forward-looking statements throughout
this news release. Forward looking statements are based on the
opinions, estimates and assumptions of management in light of
management's experience and perception of historical trends,
current conditions and expected developments at the date the
statements are made, such as current and future market conditions,
the ability to maintain SG&A costs in line with current
expectations, the ability to achieve high margin revenues in the
Canadian consumer market, the current and future regulatory
environment and future approvals and permits. Forward-looking
statements are subject to a variety of risks, uncertainties and
other factors that management believes to be relevant and
reasonable in the circumstances could cause actual events, results,
level of activity, performance, prospects, opportunities or
achievements to differ materially from those projected in the
forward-looking statements, including the risks associated with:
entering the U.S. market, the ability to realize the anticipated
benefits associated with the acquisition of Reliva, achievement of
Aurora's business transformation plan, general business and
economic conditions, changes in laws and regulations, product
demand, changes in prices of required commodities, competition, the
effects of and responses to the COVID-19 pandemic and other risks,
uncertainties and factors set out under the heading "Risk Factors"
in the Company's annual information form dated September 24, 2020 (the "AIF") and filed with
Canadian securities regulators available on the Company's issuer
profile on SEDAR at www.sedar.com and filed with and available on
the SEC's website at www.edgar.gov. The Company cautions that the
list of risks, uncertainties and other factors described in the AIF
is not exhaustive and other factors could also adversely affect its
results. Readers are urged to consider the risks, uncertainties and
assumptions carefully in evaluating the forward-looking statements
and are cautioned not to place undue reliance on such information.
The Company is under no obligation, and expressly disclaims any
intention or obligation, to update or revise any forward-looking
statements, whether as a result of new information, future events
or otherwise, except as expressly required by applicable securities
law.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/aurora-cannabis-to-host-fourth-quarter-and-full-fiscal-year-2021-investor-conference-call-and-related-year-end-informational-filings-301370692.html
SOURCE Aurora Cannabis Inc.